—

Charles River Laboratories (CRL) — Technical state

As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +15.8% vs the 50-day and +57.8% vs the 200-day average, 7.3% below the 52-week high and +140.7% off the 52-week low. Computed from daily closes. (as of 2026-11-03)
  • Trend: Charles River Laboratories trades 15.8% above its 50-day and 57.8% above its 200-day moving average. (as of 2026-11-03)

Charles River Laboratories provides drug discovery, non-clinical development, and safety testing services to pharmaceutical and biotech developers worldwide. It breeds and sells research rodents, runs in vitro and in vivo testing for new drug candidates, and offers manufacturing and quality-control testing for biologics.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the CRL overview. Research diary readings, not advice.

Uptrend stack intact

Trades +15.8% vs the 50-day and +57.8% vs the 200-day average, 7.3% below the 52-week high and +140.7% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-03

Quick answers

What is the current Closelooknet signal on CRL?

Uptrend stack intact — Trades +15.8% vs the 50-day and +57.8% vs the 200-day average, 7.3% below the 52-week high and +140.7% off the 52-week low. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is CRL above its 50-day and 200-day moving averages?

As of 2026-11-03, Charles River Laboratories trades +15.8% above its 50-day and +57.8% above its 200-day average, with the 20-day +7.1% away.

How far is CRL from its 52-week high?

7.3% below the 52-week high and 140.7% above the 52-week low, as of 2026-11-03.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.